Chicago Clinical Research Inst

Chicago, Illinois 60607

1 studies enrolling now · 6 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Osteoarthritis, Primary Prevention of Atherosclerotic Cardiovascular Disease, Systemic Lupus Erythematosus

Studies at this site

• Pelacarsen Roll-over Extension Program — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Lp(a) Lowering Study of Pelacarsen (TQJ230) in US Black/African American and Hispanic Participants With Elevated Lp(a) and Established ASCVD — Completed
• Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis — Stopped early